000 01236 a2200325 4500
005 20250516013223.0
264 0 _c20101221
008 201012s 0 0 eng d
022 _a1557-9859
024 7 _a10.1016/j.mcna.2010.08.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoehrborn, Claus G
245 0 0 _aMale lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
_h[electronic resource]
260 _bThe Medical clinics of North America
_cJan 2011
300 _a87-100 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _a5-alpha Reductase Inhibitors
_xtherapeutic use
650 0 4 _aAdrenergic alpha-Antagonists
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMuscarinic Antagonists
_xtherapeutic use
650 0 4 _aPlant Extracts
_xtherapeutic use
650 0 4 _aPrimary Health Care
650 0 4 _aProstate-Specific Antigen
650 0 4 _aProstatic Hyperplasia
_xcomplications
650 0 4 _aSerenoa
650 0 4 _aUrinary Incontinence
_xdrug therapy
773 0 _tThe Medical clinics of North America
_gvol. 95
_gno. 1
_gp. 87-100
856 4 0 _uhttps://doi.org/10.1016/j.mcna.2010.08.013
_zAvailable from publisher's website
999 _c20391581
_d20391581